SYNTHON PHARMACEUTICALS, INC., Plaintiffs,
v.
ELI LILLY AND COMPANY and ICOS CORPORATION, Defendant.
ELI LILLY AND COMPANY and ICOS CORPORATION, Plaintiffs,
v.
SYNTHON PHARMACEUTICALS, INC., Defendant.
United States District Court, E.D. North Carolina, Western Division.https://leagle.com/images/logo.png
Synthon Pharmaceuticals, Inc., Counter Defendant, represented by Mark A. Ash , McGuireWoods LLP, Robert J. Morris , Smith Anderson Blount Dorsett Mitchell & Jernigan, LLP, Tung-On Kong , Wilson Sonsini Goodrich & Rosati, P.C. & Justin Thomas Yedor , McGuireWoods, LLP.
On October 2, 2015, the court granted Eli Lilly's motion to stay actions pending resolution ofpetitions for Inter Partes Review ("IPR") of the only asserted patents in this case: IPR20 15-00561 concerning U.S. Patent No. 7,182,958 and IPR2015-00562 concerning...
Let's get started
Welcome to the leading source of independent legal reporting Sign on now to see your case. Or view more than 10 million decisions and orders.
Updated daily.
Uncompromising quality.
Complete, Accurate, Current.
Listed below are the cases that are cited in this Featured Case. Click the citation to see the full
text of the cited case. Citations are also linked in the body of the Featured Case.
Cited Cases
No Cases Found
Listed below are those cases in which this Featured Case is cited. Click on the case name to see the
full text of the citing case.